Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Dr. Jean Wang, Affiliate Scientist at the Princess Margaret Cancer Centre, has been awarded significant funding to propel her work on a promising treatment for leukemia.
Dr. Wang received $3.4 million in funding from Genome Canada's
Genomic Applications Partnership Program (GAPP).
The project, titled "SIRPαFc: Translating Genomics Research into a Novel Cancer Immunotherapy," will advance a promising treatment towards clinical trials. The therapeutic works by interfering with a protein on the surface of leukemia stem cells, known as CD47, which is thought to protect the cells from attack by the immune system.
Dr. Wang and her team are working on the project in collaboration with Dr. Jayne Danska at SickKids and Trillium Therapeutics Inc.—a biotech company based in Toronto.
Dr. Wang's lab is focused on understanding the biology of normal and leukemic human hematopoietic stem cells in order to develop more effective therapies for acute myeloid leukemia (AML).
Genome Canada is a not-for-profit organization, funded by the Government of Canada. Through funding programs like GAPP, they hope to assist in developing and applying genomics and genomic-based technologies to real world challenges.